相关实验视频

Updated: Jul 16, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

在SARS-CoV-2感染之前的基线肠道微生物组特征与COVID-19期间和之后的宿主症状有关

Tao Zuo^1,2,3,4, Guanzhan Liang^1,2,4,5, Ziyu Huang^1,2,3,4

¹Key Laboratory of Human Microbiome and Chronic Diseases, Ministry of Education, Sun Yat-sen University, Guangzhou, China.

Journal of medical virology

|September 12, 2023

概括

你的肠道微生物组组成会影响COVID-19的严重程度和持续症状. 这项研究表明,基线肠道细菌可能会以不同的方式为像SARS-CoV-2这样的病毒感染做好准备.

科学领域:

微生物学微生物学
免疫学免疫学免疫学
传染性疾病传染性疾病

背景情况:

人的肠道微生物群体表现出显著的个体和人口变异性.
微生物组的组成在基线时差异调节宿主免疫力.
这种异质性可能导致病毒感染期间的各种免疫反应和症状,包括SARS-CoV-2.

研究的目的:

调查基线肠道微生物组组成和COVID-19表现之间的关联.
探索肠道微生物组异质性如何影响对SARS-CoV-2感染的免疫反应.
为了检查肠道微生物组与COVID-19后症状之间的联系.

主要方法:

探索性,纵向研究设计.
从中国两个不同的地区招募同质的年轻参与者.
在COVID-19爆发之前收集便样本 (2022年12月).
对COVID-19和COVID-19后症状的后续评估.

主要成果:

基线肠道微生物组组成与COVID-19的表现有显著的关联.
观察到与胃肠道干扰和COVID-19后持续症状的关联.
这些联系表明了个人和人口依赖的模式.

结论:

稳定状态的肠道微生物组在对病毒性呼吸道感染的差异性免疫准备中发挥作用.
肠道微生物组的组成可能会影响COVID-19症状的严重程度和持续时间.
个性化微生物组资料可以预测对SARS-CoV-2感染的不同反应.

关键词:

新冠病毒新冠病毒新冠病毒.冠状病毒SARS 冠状病毒SARS 胃肠道分析胃肠道分析感染的感染感染.研究和分析方法研究和分析方法.病毒分类病毒分类

更多相关视频

Automated, High-Throughput Detection of Bacterial Adherence to Host Cells

Automated, High-Throughput Detection of Bacterial Adherence to Host Cells

Published on: September 17, 2021

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

相关概念视频

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: